Sun Pharmaceutical Industries Ltd. - Research Center
524715 SUNPHARMA Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 15,585.98 | 12,803.21 | 12,531.93 | 10,303.21 | 9,006.25 |
| Expenses | |||||
| Material consumed | 5,650.39 | 5,190.54 | 4,942.40 | 4,109.54 | 4,041.34 |
| Manufacturing expenses | - | 384.13 | 394.74 | 407.28 | 376.17 |
| Personnel expenses | 2,000.78 | 1,798.45 | 1,702.77 | 1,571.34 | 1,625.00 |
| Selling expenses | - | - | - | - | - |
| Adminstrative expenses | 5,027.29 | 2,494.09 | 2,780.37 | 2,458.79 | 1,985.48 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 12,678.46 | 9,867.21 | 9,820.28 | 8,546.95 | 8,027.99 |
| Operating profit | 2,907.52 | 2,936.00 | 2,711.65 | 1,756.26 | 978.26 |
| Other recurring income | 957.92 | 150.22 | 1,510.92 | 1,271.44 | 1,128.04 |
| Adjusted PBDIT | 3,865.44 | 3,086.22 | 4,222.57 | 3,027.70 | 2,106.30 |
| Financial expenses | 388.10 | 256.98 | 408.01 | 540.92 | 388.31 |
| Depreciation | 1,349.95 | 586.81 | 561.56 | 552.95 | 487.24 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 2,127.39 | 2,242.43 | 3,253.00 | 1,933.83 | 1,230.75 |
| Tax charges | 406.85 | 13.17 | 41.86 | -97.15 | -25.39 |
| Adjusted PAT | 1,720.54 | 2,229.26 | 3,211.14 | 2,030.98 | 1,256.14 |
| Non recurring items | -1,820.53 | -96.82 | -18.63 | -1,203.65 | -907.06 |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | -99.99 | 2,132.44 | 3,192.51 | 827.33 | 349.08 |
| Earnigs before appropriation | -99.99 | 16,137.71 | 15,577.12 | 12,864.33 | 12,835.08 |
| Equity dividend | - | 1,559.06 | 1,186.07 | 478.60 | 797.40 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | 192.89 | 0.56 | 0.34 |
| Retained earnings | -99.99 | 14,578.65 | 14,198.16 | 12,385.17 | 12,037.34 |
© 2022 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis